These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31746611)

  • 1. Design of
    Kashapov RR; Razuvayeva YS; Ziganshina AY; Mukhitova RK; Sapunova AS; Voloshina AD; Nizameev IR; Kadirov MK; Zakharova LY
    Mol Pharm; 2020 Jan; 17(1):40-49. PubMed ID: 31746611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.
    Ostos FJ; Lebrón JA; Moyá ML; López-López M; Sánchez A; Clavero A; García-Calderón CB; Rosado IV; López-Cornejo P
    Chem Asian J; 2017 Mar; 12(6):679-689. PubMed ID: 28112869
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kashapov RR; Razuvayeva YS; Ziganshina AY; Mukhitova RK; Sapunova AS; Voloshina AD; Syakaev VV; Latypov SK; Nizameev IR; Kadirov MK; Zakharova LY
    Molecules; 2019 May; 24(10):. PubMed ID: 31137548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Water-Soluble Amino Functionalized Multithiacalix[4]arene via Quaternization of Tertiary Amino Groups.
    Nosov R; Padnya P; Shurpik D; Stoikov I
    Molecules; 2018 May; 23(5):. PubMed ID: 29738518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthogonal Design of a Water-Soluble
    Tian X; Zuo M; Niu P; Velmurugan K; Wang K; Zhao Y; Wang L; Hu XY
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):37466-37474. PubMed ID: 34314153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method.
    Tian J; Xu S; Deng H; Song X; Li X; Chen J; Cao F; Li B
    Int J Pharm; 2017 Jan; 517(1-2):25-34. PubMed ID: 27845214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH Responsive Doxorubicin Delivery by Fluorous Polymers for Cancer Treatment.
    Wallat JD; Harrison JK; Pokorski JK
    Mol Pharm; 2018 Aug; 15(8):2954-2962. PubMed ID: 29381366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatially Directional Resorcin[4]arene Cavitand Glycoconjugates for Organic Catalysis.
    Husain AA; Maknenko AM; Bisht KS
    Chemistry; 2016 Apr; 22(18):6223-7. PubMed ID: 26933945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
    Wang X; Wang L; Tan X; Zhang H; Sun G
    J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery.
    Wang T; Li M; Gao H; Wu Y
    J Colloid Interface Sci; 2011 Jan; 353(1):107-15. PubMed ID: 20947092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
    He X; Hai L; Su J; Wang K; Wu X
    Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.